New collaboration between Pfizer and DNDi.
Pfizer Inc and Drugs for Neglected Diseases initiative (DNDi) have signed an agreement that is designed to facilitate advancements in the battle against human African trypanosomiasis (HAT), visceral leishmaniasis (VL) and Chagas disease, which afflict vulnerable populations in the developing world. Under the agreement, DNDi will have access to the Pfizer library of novel chemical entities, in order to screen it for compounds that have the potential to be developed into new treatments.
You can read more here
- BROWSE / IN TIMELINE
- « TDI presented at Duke-NUS (Singapore)
- » TDI featured in Tropika.net
- BROWSE / IN News
- « More on our TDI kernel. Now in PLoS NTD!
- » TDI featured in Tropika.net
SPEAK / ADD YOUR COMMENT
Comments are moderated.
You must be logged in to post a comment.
